Abstract
Inflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This review discusses the latest discoveries in the roles BAs play in IBD pathogenesis and explores how these discoveries offer promising new therapeutic targets to treat IBD and improve patient outcomes. Several therapies discussed include specific BA receptor (BAR) agonists, dietary therapies, supplements, probiotics, and mesenchymal stem cell therapies that have all been shown to decrease IBD disease activity.
Funding Information
  • Crohn's and Colitis Foundation (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • NIH/NIDDK K08 Clinical Investigator Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • NIH T32 Institutional Research Training Grant (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • American Gastroenterological Association (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • Digestive Disease Research Core Center (DDRCC) Pilot and Feasibility Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • Doris Duke COVID-19 Fund to Retain Clinical Scientists Program (CFRCS), Lawrence C. Pakula, MD IBD Education & Innovation Fund (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • Washington University Clinical and Translational Research Funding Program (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • Washington University Precision Health Innovation Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
  • Washington University DDRCC (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)

This publication has 231 references indexed in Scilit: